[DOI] [PMC free article] [PubMed] [Google Scholar] Ono K, Jung M, Zhang T, Tsutsuki H, Sezaki H, Ihara H, Wei FY, Tomizawa K, Akaike T, Sawa T
Emerging Roles of Inflammasomes in Cardiovascular Diseases
KLOW is a compound peptide combination that includes: TB-500 10mg BPC-157 10mg GHK-CU 50mg KPV 10mg This formulation is designed as a multi-pathway research peptide complex for research into integrated signaling and cellular communication environments
pharmaceutical grade 98% HPLC Origin: GHK was isolated from human plasma in the 1970s Loren Pickart determined that the glycine-histidine-lysine tripeptide was responsible for the observed factor influencing the behavior of liver cells in culture, and that its active form was a complex with copper (GHK-Cu)
Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia
promote the growth of hepatocytes and hematopoietic cells in culture